R

Resverlogix Corp.

24 employees

Resverlogix is a biopharmaceutical company, focused on the development of therapeutics in cardiovascular diseases and Alzheimer’s disease.

Basic info

biotechnology research

Biotechnology

Epigenetics

Atherosclerosis

Biopharma

Drug Discovery

Health Care

Therapeutics

Muscular Dystrophy

Drug Development

Cardiovascular disease

Diabetes Mellitus

Chronic Kidney Disease

Neurodegenerative diseases

2001

$25M

from 2 investors over 2 rounds

R

Resverlogix Corp. raised $10M on June 6, 2018

Investors: Efung Capital

R

Resverlogix Corp. raised $25M on March 29, 2010

Investors: Yorkville Advisors